American Society of Cytopathology

Analysis

American Society of Cytopathology is a registered charity in United States, based in Wilmington, DE. It received its IRS tax-exemption ruling in March 1975, 51 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, American Society of Cytopathology reported income of $1.6m and spending of $1.6m, spending 100% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $1.5m to $1.6m (+7.8%), an average of +1.9% a year. The sharpest change came in the year to June 2023, when income rose by 22%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, American Society of Cytopathology sits at the 69th percentile: it is larger than about 69% of them. Against every charity in United States with reported income it ranks in the 84th percentile, and in the 81st percentile within DE. Charities of a similar size with the same main cause include Clear Lake Emergency Medical Corps ($1.6m), Society of Abdominal Radiology ($1.6m) and Northeast Regional Early Intervention Collaborative Inc ($1.6m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 9.1% and program service revenue 79% of the total. Compensation of current officers, directors and key employees was $154k (9.6% of expenses). Other salaries and wages came to $292k. At year end it held assets of $2.1m against liabilities of $208k, net assets of $1.9m. It reported 6 employees.